|
| Index | Pathway ID and name | The rank of related features (+/−)a |
|
| 1 | hsa05215 prostate cancer | 2 (−) |
| 2 | hsa04964 proximal tubule bicarbonate reclamation | 3 (+), 48 (−) |
| 3 | hsa00140 steroid hormone biosynthesis | 5 (−) |
| 4 | hsa04145 phagosome | 6 (+) |
| 5 | hsa05150 staphylococcus aureus infection | 7 (−) |
| 6 | hsa04973 carbohydrate digestion and absorption | 8 (−) |
| 7 | hsa04340 hedgehog signaling pathway | 9 (−) |
| 8 | hsa00052 galactose metabolism | 10 (+) |
| 9 | hsa04310 wnt signaling pathway | 11 (−) |
| 10 | hsa00531 glycosaminoglycan degradation | 12 (+) |
| 11 | hsa04972 pancreatic secretion | 13 (+) |
| 12 | hsa04976 bile secretion | 14 (−) |
| 13 | hsa03018 rNA degradation | 15 (−) |
| 14 | hsa04744 phototransduction | 16 (−) |
| 15 | hsa04977 vitamin digestion and absorption | 17 (−) |
| 16 | hsa04330 notch signaling pathway | 18 (−) |
| 17 | hsa00430 taurine and hypotaurine metabolism | 19 (−) |
| 18 | hsa05130 pathogenic Escherichia coli infection | 20 (−) |
| 19 | hsa00920 sulfur metabolism | 21 (+) |
| 20 | hsa00785 lipoic acid metabolism | 22 (−) |
| 21 | hsa05020 prion diseases | 23 (+), 54 (−) |
| 22 | hsa00511 other glycan degradation | 24 (+) |
| 23 | hsa04320 dorso-ventral axis formation | 26 (−) |
| 24 | hsa00520 amino sugar and nucleotide sugar metabolism | 27 (−) |
| 25 | hsa00310 lysine degradation | 28 (−) |
| 26 | hsa00270 cysteine and methionine metabolism | 29 (−) |
| 27 | hsa04115 p53 signaling pathway | 30 (−) |
| 28 | hsa04966 collecting duct acid secretion | 31 (+) |
| 29 | hsa00830 retinol metabolism | 32 (−) |
| 30 | hsa00910 nitrogen metabolism | 33 (−) |
| 31 | hsa05217 basal cell carcinoma | 34 (−) |
| 32 | hsa05010 alzheimer's disease | 35 (−) |
| 33 | hsa04150 mTOR signaling pathway | 36 (−) |
| 34 | hsa00532 glycosaminoglycan biosynthesis chondroitin sulfate | 37 (+) |
| 35 | hsa04514 cell adhesion molecules (CAMs) | 38 (−) |
| 36 | hsa04975 fat digestion and absorption | 39 (−) |
| 37 | hsa05110 vibrio cholerae infection | 40 (+) |
| 38 | hsa05416 viral myocarditis | 41 (−) |
| 39 | hsa05012 parkinson's disease | 42 (−) |
| 40 | hsa04614 renin-angiotensin system | 43 (−) |
| 41 | hsa04130 SNARE interactions in vesicular transport | 44 (+) |
| 42 | hsa00480 glutathione metabolism | 45 (+) |
| 43 | hsa05211 renal cell carcinoma | 46 (+) |
| 44 | hsa05322 systemic lupus erythematosus | 47 (−) |
| 45 | hsa04120 ubiquitin mediated proteolysis | 49 (+) |
| 46 | hsa00780 biotin metabolism | 50 (+) |
| 47 | hsa00630 glyoxylate and dicarboxylate metabolism | 51 (−) |
| 48 | hsa00510 n-glycan biosynthesis | 52 (−) |
| 49 | hsa00061 fatty acid biosynthesis | 53 (−) |
| 50 | hsa00232 caffeine metabolism | 55 (−) |
|
